Category: Partnerships
Ann Arbor, MI USA and Milan, Italy (November 25, 2019) – NeuMoDx™ Molecular, a sample-to-result molecular diagnostic company focused on developing testing solutions for hospital and commercial reference laboratory customers, and Sentinel Diagnostics, a leading company engaged in the development and production of diagnostic kits for Clinical Chemistry, Immunochemistry and Molecular Biology, announced today their...
Ann Arbor, MI (October 16, 2019) – NeuMoDx™ Molecular, a sample-to-result molecular diagnostic company focused on central laboratory customers, announced today an agreement with Self-screen BV to implement a CE-IVD marked molecular diagnostic test for high-risk strains of human papillomavirus (HPV) on the NeuMoDx™ 288 and NeuMoDx™ 96 Molecular Systems. HPV is the virus regarded...
NeuMoDx™ plans to deliver 11 CE-IVD assays to QIAGEN by the end of 2019 on NeuMoDx™ System as part of aggressive menu expansion plans, including blood-borne viruses, women’s health and transplantation assays Hilden, Germany, and Ann Arbor, Michigan, April 11, 2019 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) and NeuMoDx™ Molecular, Inc....
QIAGEN to launch two Sample to Insight systems in Europe and other markets, NeuMoDx™ to commercialize in the U.S. / Initial assay menu for infectious diseases and LDTs Hilden, Germany, and Ann Arbor, Michigan, September 17, 2018 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) and NeuMoDx™ Molecular, Inc. today announced a strategic partnership to...